期刊文献+

Intrahepatic cholangiocarcinoma: review and update 被引量:1

原文传递
导出
摘要 Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies that could develop at any level from the biliary tree. CCA is currently classified into intrahepatic (iCCA), perihilar and distal on the basis of its anatomical location. Of note, these three CCA subtypes have common features but also important inter-tumor and intra-tumor differences that can affect the pathogenesis and outcome. A unique feature of iCCA is that it recognizes as origin tissues, the hepatic parenchyma or large intrahepatic and extrahepatic bile ducts, which are furnished by two distinct stem cell niches, the canals of Hering and the peribiliary glands, respectively. The complexity of iCCA pathogenesis highlights the need of a multidisciplinary, translational and systemic approach to this malignancy. This review will focus on the advances of iCCA epidemiology, histo-morphology, risk factors, molecular pathogenesis, revealing the existence of multiple subsets of iCCA.
出处 《Hepatoma Research》 2018年第6期25-40,共16页 肝癌研究(英文版)
  • 相关文献

参考文献6

二级参考文献138

  • 1Yan-Ming Zhou, Lu Cao, Bin Li, Xiu-Zhong Zhang, Zheng-Feng Yin Department of Hepato-Biliary-Pancreato-Vascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen 361003, China,Department of Molecular Oncology,Department of Pathology, Eastern Hepatobiliary Surgery Hospital,Second Military Medical University, Shanghai 200438, China.Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2012,11(5):532-535. 被引量:9
  • 2Morrissey C, Martinez A, Zatyka M, et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear ceel and papillary renal cell carcinoma. Cancer Res, 2001,61(19) :7277-7281.
  • 3Yoon JH,Dammann R, Heifer GP.Hypermethylation of the CpG island of the RASSF1A gene in overian and renal cell carcinomas. Int J Cancer,2001,94(2) :212-217
  • 4Lee MG, Kim HY, Byun DS, et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res, 2001,61(18) :6688-6692.
  • 5Agathanggelou A, Honorio S,Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene, 2001,20(12) :1509-1518.
  • 6Khokhlatchev A, Rabizadeh S, Xavier R, et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol, 2002,12(4) :253-265.
  • 7Ortic-Vega S, Khokhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Norel. Oncogene, 2002,21(9): 1381-1390.
  • 8Vos MD, Ellis CA, Bell A, et al. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem, 2000,275(46):35669-35672.
  • 9Vos MD, Ellis CA, Elam C,et al. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem, 2003,278 (30): 28045-28051.
  • 10Isa T, Tomita S, N.akachi A, et al. Analysis of microsatellite instability, Kras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma. Hepatogastroenterology, 2002,49(45) :604-608.

共引文献148

同被引文献18

引证文献1

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部